1. Nitsche U., Wenzel P., Siveke J.T., Braren R., Holzapfel K., Schlitter A.M., Stöß C., Kong B., Esposito I., Erkan M., Michalski C.W., Friess H., Kleeff J. Resectability after first-line FOLFIRINOX in initially unresectable locally advanced pancreatic cancer: a single-center experience. Ann. Surg. Oncol. 2015; 22 (3): 1212-1220. https://doi.org/10.1245/s10434-015-4851-2
2. Callery M.P., Chang K.J., Fishman E.K., Talamonti M.S., Traverso L.V., Linehan D.C. Pretreatment assessment of resectable and borderline resectable pancreatic cancer: еxpert consensus statement. Ann. Surg. Oncol. 2009; 16 (7): 1727-1733. https://doi.org/10.1245/s10434-009-0408-6
3. Petrelli F., Coinu A., Borgonovo K., Cabiddu M., Ghilardi M., Lonati V., Aitini V., Barni S. FOLFIRINOX-based neoadjuvant therapy in borderline resectable or unresectable pancreatic cancer: a meta-analytical review of published studies. Pancreas. 2015; 44 (4): 515-521. https://doi.org/10.1097/MPA.0000000000000314
4. Bassi C., Marchegiani G., Dervenis C. et al.; International Study Group on Pancreatic Surgery (ISGPS). The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 years after. Surgery. 2017; 161 (3): 584-591. https://doi.org/10.1016/j.surg.2016.11.014
5. Nahm C.B., Connor S.J., Samra J.S., Mittal A. Postoperative pancreatic fistula: a review of traditional and emerging concepts. Clin. Exp. Gastroenterol. 2018; 15 (11): 105-118. https://doi.org/10.2147/CEG.S120217
6. Keck T., Wellner U.F., Bahra M., Klein F., Sick O., Niedergethmann M., Wilhelm T.J., Farkas S.A., Börner T., Bruns C., Kleespies A., Kleeff J., Mihaljevic A.L., Uhl W., Chromik A., Fendrich V., Heeger K., Padberg W., Hecker A., Neumann U.P., Junge K., Kalff J.C., Glowka T.R., Werner J., Knebel P., Piso P., Mayr M., Izbicki J., Vashist Y., Bronsert P., Bruckner T., Limprecht R., Diener M.K., Rossion I., Wegener I., Hopt U.T. Pancreatogastrostomy versus pancreatojejunostomy for RECOnstruction after PANCreatoduodenectomy (RECOPANC, DRKS 00000767): perioperative and long-term results of a multicenter randomized controlled trial. Ann. Surg. 2017; 263 (3): 440-449. https://doi.org/10.1097/SLA.0000000000001240
7. Shrikhande S.V., Sivasanker M., Vollmer S.M., Friess H., Besselink M.G., Fingerhut A., Yeo C.J., Fernandez-Del Castillo C., Dervenis C., Halloran C., Gouma D.J., Radenkovic D., Asbun H.J., Neoptolemos J.P., Izbicki J.R., Lillemoe K.D., Conlon K.C., Fernandez-Cruz L., Montorsi M., Bockhorn M., Adham M., Charnley R., Carter R., Hackert T., Hartwig W., Miao Y., Sarr M., Bassi C., Büchler M.W.; International Study Group of Pancreatic Surgery (ISGPS). Pancreatic anastomosis after pancreatoduodenectomy: a position statement by the International Study Group of Pancreatic Surgery (ISGPS). Surgery (United States). 2017; 161 (5): 1221-1234. https://doi.org/10.1016/j.surg.2016.11.021
8. Pedrazzoli S. Pancreatoduodenectomy (PD) and postoperative pancreatic fistula (POPF). Medicine (Baltimore). 2017; 96 (19): e6858. https://doi.org/10.1097/MD.0000000000006858
9. Schuh F., Mihaljevic A.L., Probst P., Trudeau M.T., Müller P.C., Marchegiani G., Besselink M.G., Uzunoglu F., Izbicki J.R., Falconi M., Castillo C.F., Adham M., Z'graggen K., Friess H., Werner J., Weitz J., Strobel O., Hackert T., Radenkovic D., Kelemen D., Wolfgang C., Miao Y.I., Shrikhande S.V., Lillemoe K.D., Dervenis C., Bassi C., Neoptolemos J.P., Diener M.K., Vollmer C.M. Jr., Büchler M.W. A Simple classification of pancreatic duct size and texture predicts postoperative pancreatic fistula: a classification of the International Study Group of Pancreatic Surgery. Ann. Surg. 2023; 277 (3): e597-e608. https://doi.org/10.1097/SLA.0000000000004855
10. Suurmeijer J.A., Emmen A.M., Bonsing B.A., Busch O.R., Daams F., van Eijck C.H., van Dieren S., de Hingh I.H., Mackay T.M., Mieog J.S., Molenaar I.Q., Stommel M.W., de Meijer V.E., van Santvoort H.C., Groot Koerkamp B., Besselink M.G.; Dutch Pancreatic Cancer Group. Nationwide validation of the ISGPS risk classification for postoperative pancreatic fistula after pancreatoduodenectomy: “Less is more”. Surgery. 2023; 173 (5): 1248-1253. https://doi.org/10.1016/j.surg.2023.01.004
11. Коваленко З.А., Ефанов М.Г. Шкалы прогноза панкреатической фистулы после операции Уиппла. Хирургия. Журнал им. Н.И. Пирогова. 2021; 7: 71-76. https://doi.org/10.17116/hirurgia202107171
12. Callery M.P., Pratt W.B., Kent T.S., Chaikof E.L., Vollmer Jr C.M. A prospectively validated clinical risk score accurately predicts pancreatic fistula after pancreatoduodenectomy. J. Am. Coll. Surg. 2013; 216 (1): 1-14. https://doi.org/10.1016/j.jamcollsurg.2012.09.002
13. Mungroop T.H., Klompmaker S., Wellner U.F., Steyerberg E.W., Coratti A., D'Hondt M., de Pastena M., Dokmak S., Khatkov I., Saint-Marc O., Wittel U., Abu Hilal M., Fuks D., Poves I., Keck T., Boggi U., Besselink M.G.; European Consortium on Minimally Invasive Pancreatic Surgery (E-MIPS). Updated Alternative Fistula Risk Score (ua-FRS) to include minimally invasive pancreatoduodenectomy: pan-European validation. Ann. Surg. 2021; 273 (2): 334-340. https://doi.org/10.1097/SLA.0000000000003234
14. Miller B.C., Christein J.D., Behrman S.W., Drebin J.A., Pratt W.B., Callery M.P., Vollmer Jr C.M. A Multi-Institutional external validation of the Fistula Risk Score for pancreato-duodenectomy. J. Gastrointest. Surg. 2014; 18 (1): 172-179; discussion 179-180. https://doi.org/10.1007/s11605-013-2337-8
15. Kantor O., Talamonti M.S., Pitt H.A., Vollmer C.M., Riall T.S., Hall B.L., Wang C.-H., Baker M.S. Using the NSQIP pancreatic demonstration project to derive a modified Fistula Risk Score for preoperative risk stratification in patients undergoing pancreaticoduodenectomy. J. Am. Coll. Surg. 2017; 224 (5): 816-825. https://doi.org/10.1016/j.jamcollsurg.2017.01.054
16. Teränen V., Rinta-Kiikka I., Holli-Helenius K., Laaninen M., Sand J., Laukkarinen J. Perioperative acinar cell count method works well in the prediction of postoperative pancreatic fistula and other postoperative complications after pancreatico-duodenectomy. Pancreatology. 2021; 21 (2): 487-493. https://doi.org/10.1016/j.pan.2021.01.005
17. Jabłońska B., Mrowiec S. Pancreatectomy and pancreatic surgery. Life. 2023; 13 (6): 1400. https://doi.org/10.3390/life13061400
18. Shi Y., Gao F., Qi Y., Lu H., Ai F., Hou Y., Liu C., Xu Y., Zhang X., Cai X. Computed tomography-adjusted Fistula Risk Score for predicting clinically relevant postoperative pancreatic fistula after pancreatoduodenectomy: training and external validation of model upgrade. EBioMedicine. 2020; 62: 103096. https://doi.org/10.1016/j.ebiom.2020.103096
19. Tian X., Li J., Gao H., Zhuang Y., Ma Y., Chen Y., Xie X., Yang Y. Prognostic factors for disease-free survival in patients with pancreatic ductal adenocarcinoma after surgery. J. Pancreatol. 2019; 2 (1): 22-27. https://doi.org/10.1097/JP9.0000000000000011
20. Горин Д.С., Кригер А.Г., Галкин Г.В., Калинин Д.В., Глотов А.В., Калдаров А.Р., Гальчина Ю.С., Берелавичус С.В. Прогнозирование возникновения панкреатического свища после панкреатодуоденальной резекции. Хирургия. Журнал им. Н.И. Пирогова. 2020; 7: 61-67. https://doi.org/10.17116/hirurgia202007161
21. Гальчина Ю.С., Кармазановский Г.Г., Калинин Д.В., Кондратьев Е.В., Горин Д.С., Галкин Г.В., Кригер А.Г. Критерии диагностики “мягкой” поджелудочной железы и их влияние на возникновение панкреатического свища после панкреатодуоденальной резекции. Анналы хирургической гепатологии. 2020; 25 (2): 113-123. https://doi.org/10.16931/1995-5464.20202113-123
22. Belyaev O., Herden H., Meier J.J., Muller C.A., Seelig M.H., Herzog T., Tannapfel A., Schmidt W.E., Uhl W. Assessment of pancreatic hardness-surgeon versus durometer. J. Surg. Res. 2010; 158 (1): 53-60. https://doi.org/10.1016/j.jss.2008.08.022
23. Belyaev O., Munding J., Herzog T., Suelberg D., Tannapfel A., Schmidt W.E., Muller C.A., Uhl W. Histomorphological features of the pancreatic remnant as independent risk factors for postoperative pancreatic fistula: a matched-pairs analysis. Pancreatology. 2011; 11 (5): 516-524. https://doi.org/10.1159/000332587
24. Marchegiani G., Ballarin R., Malleo G., Andrianello S., Allegrini W., Pulvirenti A., Paini M., Secchettin E., Boriero F., Benedetto F.Z., Bassi C., Salvia R. Quantitative assessment of pancreatic texture using a durometer: a new tool to predict the risk of developing a postoperative fistula. World J. Surg. 2017; 41 (11): 2876-2883. https://doi.org/10.1007/s00268-017-4073-9
25. Okano K., Oshima M., Kakinoki K., Yamamoto N., Akamoto S., Yachida S., Hagiike M., Kamada H., Masaki T., Suzuki Y. Pancreatic thickness as a predictive factor for postoperative pancreatic fistula after distal pancreatectomy using an endopath stapler. Surg. Today. 2013; 43 (2): 141-147. https://doi.org/10.1007/s00595-012-0235-4
26. Frozanpor F., Loizou L., Ansorge C., Segersvärd R., Lundell L., Albiin N. Preoperative pancreas CT/MRI characteristics predict fistula rate after pancreaticoduodenectomy. World J. Surg. 2012; 36 (8): 1858-1865. https://doi.org/10.1007/s00268-012-1567-3
27. Kirihara Y., Takahashi N., Hashimoto Y., Sclabas M.G., Khan S., Moriya T., Sakagami J., Huebner M., Sarr G.M., Farnell B.M. Prediction of pancreatic anastomotic failure after pancreatoduodenectomy: the use of preoperative, quantitative computed tomography to measure remnant pancreatic volume and body composition. Ann. Surg. 2013; 257 (3): 512-519. https://doi.org/10.1097/SLA.0b013e31827827d0
28. Kitagawa Y., Ishihara R., Ishikawa H., Ito Y., Oyama T., Oyama T., Kato K., Kato H., Kawakubo H., Kawachi H., Kuribayashi S., Kono K., Kojima T., Takeuchi H., Tsushima T., Toh Y., Nemoto K., Booka E., Makino T., Matsuda S., Matsubara H., Mano M., Minashi K., Miyazaki T., Muto M., Yamaji T., Yamatsuji T., Yoshida M. Pancreas-visceral fat CT value ratio and serrated pancreatic contour are strong predictors of postoperative pancreatic fistula after pancreaticojejunostomy. BMC Surg. 2020; 20 (1): 1-12. https://doi.org/10.1186/s12893-020-00785-w
29. Ingwersen E.W., Bereska J.I., Balduzzi A., Janssen B.V., Besselink M.G., Kazemier G., Marchegiani G., Malleo G., Marquering H.A., Nio C.Y., de Robertis R., Salvia R., Steyerberg E.W., Stoker J., Struik F., Verpalen I.M., Daams F. Radiomics preoperative-Fistula Risk Score (RAD-FRS) for pancreatoduodenectomy: development and external validation. BJS Open. 2023; 7 (5): 1-7. https://doi.org/10.1093/bjsopen/zrad100
30. Petrova E., Lapshyn H., Bausch D., D'Haese J., Werner J., Klier T., Nüssler N.C., Gaedcke J., Ghadimi M., Uhl W., Belyaev O., Kantor O., Baker M., Keck T., Wellner U.F. The pancreatic surgery registry (StuDoQ|Pancreas) of the German Society for General and Visceral Surgery (DGAV) - presentation and systematic quality evaluation. Pancreatology. 2017; 18 (1): 17-25. https://doi.org/10.1016/j.pan.2018.11.008
31. Wang K., Dong S.-S., Zhang W., Ni Y.-Y., Xie F., Wang J.C., Wang X.H., Li Y.-W. Surgical methods influence on the risk of anastomotic fistula after pancreaticoduodenectomy: a systematic review and network meta-analysis. Surg. Endosc. 2023; 37 (5): 3380-3397. https://doi.org/10.1007/s00464-022-09832-4
32. Yeo C.J., Cameron J.L., Maher M.M., Sauter P.K., Zahurak M.L., Talamini M.A., Lillemoe K.D., Pitt H.A. A prospective randomized trial of pancreaticogastrostomy versus pancreaticojejunostomy after pancreaticoduodenectomy. Ann. Surg. 1995; 222 (4): 580-592. https://doi.org/10.1097/00000658-199510000-00014
33. Hai H., Li Z., Zhang Z., Cheng Y., Liu Z., Gong J., Deng Y. Duct-to-mucosa versus other types of pancreaticojejunostomy for the prevention of postoperative pancreatic fistula following pancreaticoduodenectomy. Cochrane Database Syst. Rev. 2022; 3 (3): CD01346. https://doi.org/10.1002/14651858.CD013462.pub2
34. Halloran C.M., Neoptolemos J.P., Jackson R., Platt K., Psarelli E.E., Reddy S., Gomez D., O'Reilly D.A., Smith A., Pausch T.M., Prachalias A., Davidson B., Ghaneh P. A Multicenter, randomized, double-blinded, clinical trial comparing Cattell-Warren and Blumgart anastomoses following partial pancreatoduodenectomy. Ann. Surg. Open. 2022; 3 (3): e198. https://doi.org/10.1097/AS9.0000000000000198
35. Jiang Y., Chen Q., Shao Y., Gao Z., Jin M., Gao B., Zhou B., Yan S. The prognostic value of external vs internal pancreatic duct stents after pancreaticoduodenectomy in patients with FRS ≥ 4: a retrospective cohort study. BMC Surg. 2021; 21 (1): 1-8. https://doi.org/10.1186/s12893-021-01074-w
36. Salvia R., Lionetto G., Perri G., Malleo G., Marchegiani G. Total pancreatectomy and pancreatic fistula: friend or foe? Updates Surg. 2021; 73 (4): 1231-1236. https://doi.org/10.1007/s13304-021-01130-3
37. Motoi F., Egawa S., Rikiyama T., Katayose Y., Unno M. Randomized clinical trial of external stent drainage of the pancreatic duct to reduce postoperative pancreatic fistula after pancreaticojejunostomy. Br. J. Surg. 2012; 99 (4): 524-531. https://doi.org/10.1002/bjs.8654
38. Codjia T., Roussel E., Papet E., Pinson J., Monge M., Tortajada P., Tuech J.-J., Schwarz L. Can the realization of an external wirsungostomy be an option for high-risk pancreatic anastomosis after pancreaticoduodenectomy? World J. Surg. 2023; 47 (6): 1533-1539. https://doi.org/10.1007/s00268-023-06927-4
39. Casadei R., Ricci C., Taffurelli G., Guariniello A., Di Gioia A., Di Marco M., Pagano N., Serra C., Calculli L., Santini D., Minni F. Is total pancreatectomy as feasible, safe, efficacious, and cost-effective as pancreaticoduodenectomy? A single center, prospective, observational study. J. Gastrointest. Surg. 2016; 20 (9): 1595-1607. https://doi.org/10.1007/s11605-016-3201-4
40. Janot M.S., Belyaev O., Kersting S., Chromik A.M., Seelig M.H., Sülberg D., Mittelkötter U., Uhl W.H. Indications and early outcomes for total pancreatectomy at a high-volume pancreas center. HPB Surg. 2010; 2010: 686702. https://doi.org/10.1155/2010/686702
41. Del Chiaro M., Rangelova E., Segersvärd R., Arnelo U. Are there still indications for total pancreatectomy? Updates Surg. 2016; 68 (3): 257-263. https://doi.org/10.1007/s13304-016-0388-6
42. Ducreux M., Cuhna A.S., Caramella C., Hollebecque A., Burtin P., Goéré D., Seufferlein T., Haustermans K., Van Laethem J.L., Conroy T., Arnold D.; ESMO Guidelines Committee. Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 2015; 26 (5): v56-v68. https://doi.org/10.1093/annonc/mdv295
43. Arkadopoulos N., Kyriazi M.A., Papanikolaou I.S., Vasiliou P., Theodoraki K., Lappas C., Oikonomopoulos N., Smyrniotis V. Preoperative biliary drainage of severely jaundiced patients increases morbidity of pancreaticoduodenectomy: results of a case-control study. World J. Surg. 2014; 38 (11): 2967-2972. https://doi.org/10.1007/s00268-014-2669-x
44. Rashid Z., Musaab Munir M., Woldesenbet S., Khalil M., Katayama E., Muntazir Mehdi Khan M., Endo Y., Altaf A., Tsai S., Dillhoff M., Pawlik T. Association of preoperative cholangitis with outcomes and expenditures among patients undergoing pancreaticoduodenectomy. J. Gastrointest. Surg. 2024; 28 (7): 1137-1144. https://doi.org/10.1016/j.gassur.2024.05.009
45. D'Angelica M.I., Ellis R.J., Liu J.B., Brajcich B.C., Gönen M., Thompson V.M., Cohen M.E., Seo S.K., Zabor E.C., Babicky M.L., Bentrem D.J., Behrman S.W., Bertens K.A., Celinski S.A., Chan C.H.F., Dillhoff M., Dixon M.E.B., Fernandez-Del Castillo C., Gholami S., House M.G., Karanicolas P.J., Lavu H., Maithel S.K., McAuliffe J.C., Ott M.J., Reames B.N., Sanford D.E., Sarpel U., Scaife C.L., Serrano P.E., Smith T., Snyder R.A., Talamonti M.S., Weber S.M., Yopp A.C., Pitt H.A., Ko C.Y. Piperacillin-Tazobactam compared with cefoxitin as antimicrobial prophylaxis for pancreatoduodenectomy: a randomized clinical trial. JAMA. 2023; 329 (18): 1579-1588. https://doi.org/10.1001/jama.2023.5728
Послать статью по эл. почте 